Evidence map›Paper›PMID 29076073›Full record

ArticleJournal of microbiology (Seoul, Korea)2017

Dense Granule Protein-7 (GRA-7) of Toxoplasma gondii inhibits viral replication in vitro and in vivo.

Prasanna Weeratunga, Thilina U B Herath, Tae-Hwan Kim, Hyun-Cheol Lee, Jae-Hoon Kim, Byeong-Hoon Lee, Eun-Seo Lee, Kiramage Chathuranga, W A Gayan Chathuranga, Chul-Su Yang and 2 more

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of microbiology (Seoul, Korea), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Study of dense granule proteins inFrontiers in immunology · 2025
    Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Prasanna WeeratungaCollege of Veterinary Medicine, Chungnam National University, Daejeon, 34134, Republic of Korea.
Thilina U B HerathCollege of Veterinary Medicine, Chungnam National University, Daejeon, 34134, Republic of Korea.
Tae-Hwan KimCollege of Veterinary Medicine, Chungnam National University, Daejeon, 34134, Republic of Korea.
Hyun-Cheol LeeCollege of Veterinary Medicine, Chungnam National University, Daejeon, 34134, Republic of Korea.
Jae-Hoon KimCollege of Veterinary Medicine, Chungnam National University, Daejeon, 34134, Republic of Korea.
Byeong-Hoon LeeCollege of Veterinary Medicine, Chungnam National University, Daejeon, 34134, Republic of Korea.
Eun-Seo LeeCollege of Veterinary Medicine, Chungnam National University, Daejeon, 34134, Republic of Korea.
Kiramage ChathurangaCollege of Veterinary Medicine, Chungnam National University, Daejeon, 34134, Republic of Korea.
W A Gayan ChathurangaCollege of Veterinary Medicine, Chungnam National University, Daejeon, 34134, Republic of Korea.
Chul-Su YangDepartment of Molecular and Life Science, College of Science and Technology, Hanyang University, Ansan, 15588, Republic of Korea.
Jin Yeul MaKorean Medicine (KM) Application Center, Korea Institute of Oriental Medicine, Daegu, 41062, Republic of Korea.
Jong-Soo LeeCollege of Veterinary Medicine, Chungnam National University, Daejeon, 34134, Republic of Korea. jongsool@cnu.ac.kr.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Dense granule protein-7 (GRA-7) is an excretory protein of Toxoplasma gondii. It is a potential serodiagnostic marker and vaccine candidate for toxoplasmosis. Previous reports demonstrated that GRA-7 induces innate immune responses in macrophages by interacting with TRAF6 via the MyD88-dependent pathway. In the present study, we evaluated the antiviral activity and induction of an antiviral state by GRA-7 both in vitro and in vivo. It was observed that GRA-7 markedly reduced the replication of vesicular stomatitis virus (VSV-GFP), influenza A virus (PR8-GFP), coxsackievirus (H3-GFP), herpes simplex virus (HSV-GFP), and adenovirus-GFP in epithelial (HEK293T/HeLa) and immune (RAW264.7) cells. These antiviral activities of GRA-7 were attributed to the induction of type I interferon (IFN) signaling, resulting in the secretion of IFNs and pro-inflammatory cytokines. Additionally, in BALB/c mice, intranasal administration of GRA-7 prevented lethal infection by influenza A virus (H1N1) and exhibited prophylactic effects against respiratory syncytial virus (RSV-GFP). Collectively, these results suggested that GRA-7 exhibits immunostimulatory and broad spectrum antiviral activities via type I IFN signaling. Thus, GRA-7 can be potentially used as a vaccine adjuvant or as a candidate drug with prophylactic potential against viruses.

Indexed as

AnimalsAntiviral AgentsCytokinesEnterovirusFemaleHEK293 CellsHeLa CellsHumansInfluenza A virusInfluenza A Virus, H1N1 SubtypeInfluenza, HumanInterferon Type IMiceMice, Inbred BALB COrthomyxoviridae InfectionsProtozoan ProteinsAntiviral AgentsCytokinesInterferon Type IProtozoan Proteinsantiviral activityGRA-7Toxoplasma gondii

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.